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Abstract
Background: From the 17th to 19th January 2012, a group of 92 college students and teachers attended a retreat in a hotel
located on Pangkor Island, off the west coast of Peninsular Malaysia. Following the onset of symptoms in many participants
who presented to our institute, an investigation was undertaken which ultimately identified Sarcocystis nesbitti as the cause
of this outbreak.
Methodology/Principal Findings: All retreat participants were identified, and clinical and epidemiological information was
obtained via clinical review and self-reported answers to a structured questionnaire. Laboratory, imaging and muscle biopsy
results were evaluated and possible sources of exposure, in particular water supply, were investigated. At an average of 9–
11 days upon return from the retreat, 89 (97%) of the participants became ill. A vast majority of 94% had fever with 57% of
these persons experiencing relapsing fever. Myalgia was present in 91% of patients. Facial swelling from myositis of jaw
muscles occurred in 9 (10%) patients. The median duration of symptoms was 17 days (IQR 7 to 30 days; range 3 to 112). Out
of 4 muscle biopsies, sarcocysts were identified in 3. S. nesbitti was identified by PCR in 3 of the 4 biopsies including one
biopsy without observed sarcocyst. Non-Malaysians had a median duration of symptoms longer than that of Malaysians
(27.5 days vs. 14 days, p = 0.001) and were more likely to experience moderate or severe myalgia compared to mild myalgia
(83.3% vs. 40.0%, p = 0.002).
Conclusions/Significance: The similarity of the symptoms and clustered time of onset suggests that all affected persons
had muscular sarcocystosis. This is the largest human outbreak of sarcocystosis ever reported, with the specific Sarcocystis
species identified. The largely non-specific clinical features of this illness suggest that S. nesbitti may be an under diagnosed
infection in the tropics.
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Introduction
Sarcocystis spp. are intracellular protozoan parasites which may
involve humans either as definitive or intermediate hosts.
Humans are definitive hosts for Sarcocystis hominis and Sarcocystis
suihominis, acquired by consuming undercooked sarcocyst-con-
taining beef or pork, respectively. Humans can also become
accidental intermediate hosts for other Sarcocystis species by
consuming food or water contaminated with fecal sporocysts from
an infected definitive host. In such cases, hematogenous
dissemination can occur with invasion of muscle leading to
sarcocysts [1].
As a disease, sarcocystosis is noted in a variety of animals [2] but
symptomatic human disease appears to be less common, with
fewer than 150 cases reported in the literature [1,3,4]. The
prevalence of incidental sarcocysts in humans is also difficult to
establish. A previous report showed a series of autopsy tongue
muscle collected in the University of Malaya Medical Centre
(UMMC), Malaysia, to be positive for sarcocysts in 21% of cases
[5], yet, of the more than 1,500 limb muscle biopsies received in
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the past 20 years in the same centre for routine diagnosis of various
symptomatic muscle diseases, none have yielded any sarcocyst-
positive tissue (Wong KT, unpublished data).
The largest clustered outbreak of symptomatic muscular
sarcocystosis previously reported was in 6 American military
servicemen involved in a Malaysian jungle mission [3]. There were
also recent reports involving a total of 100 foreign persons with
sporadic acute muscular Sarcocystis-like illness after returning from
Tioman Island, off the east coast of Peninsular Malaysia, between
2011 and 2012 [4]. The association of S. nesbitti infection with
symptomatic human sarcocystosis has also been recognized
recently [6,7]. Herein, we report symptomatic muscular sarcocys-
tosis affecting 89 of 92 persons following a retreat in January 2012
in Pangkor Island, off the west coast of Peninsular Malaysia. This
report adds to previous molecular work [6,7] and limited clinical
studies by providing a comprehensive overview of the clinical
features and time course of the illness. Furthermore, the role and
results of blood and imaging investigations, and muscle biopsy, in
influencing diagnosis and a consideration of management options
is presented.
Methods
Case Definition and Outbreak Investigation
A case was defined as a person who attended a specified retreat
at a hotel on Pangkor Island, Malaysia, from the 17th to 19th
January 2012, and developed relevant clinical symptoms (fever,
headache, myalgia and/or arthralgia) within 28 days upon return.
Cases were subsequently defined as ‘definite sarcocystosis’ if there
was histological demonstration or nucleotide sequences of
Sarcocystis spp. from muscle tissue. The remaining cases were
defined as ‘probable sarcocystosis’. All persons who attended the
retreat, whether or not they had medical reviews at UMMC,
submitted self-reported responses to a structured questionnaire
aimed at ensuring that all cases were identified. To further
elucidate the clinical features, participants were asked about the
duration of symptoms, episodes of relapse and to describe the
severity of myalgia. Myalgia was defined as ‘severe’, if ‘‘excruci-
ating’’ pain was experienced, ‘moderate’, if daily activities were
affected and analgesics required, and ‘mild’ if daily activities were
not affected and analgesics not required. Fever referred to a
subjective sensation of fever as reported by the patient. If there was
any conflicting information between the initial medical review and
questionnaire responses, the medical review was taken as more
accurate. Participants were also questioned regarding activities
and food or water exposure to ascertain potential exposure risks
during the retreat. They were also asked if any family members or
contacts who did not attend the retreat reported similar symptoms.
To investigate possible sources of infection, water samples were
examined as previously described [8]. Ten litre samples were
collected from different places along the ‘‘gravity-feed’’ water
supply system (up-, middle, down stream of the water source, and
from water tanks in the hotel) approximately 3 months after the
outbreak.
Investigations
Investigations included full blood counts (FBC), renal function
tests (RFT), liver function tests (LFT), serum creatine kinase (CK)
levels, chest x-rays, blood cultures, and blood films for malarial
parasites. Results were considered ‘early’ if obtained before 12th
February 2012 (less than 4 weeks after the start of the retreat) or
‘late’ if obtained after.
Serological testing was done for chikungunya and dengue
viruses, Legionella, Mycoplasma, and Leptospira. Testing was per-
formed using an immunofluorescence assay (in-house) for detec-
tion of chikungunya IgM and IgG; anti-dengue IgM and IgG
capture ELISA (Standard Diagnostics, Inc, Korea) for detection of
dengue IgM and IgG; immunofluorescence assays for detection of
Legionella IgG (MarDx Diagnostics, Inc, Ireland) and Legionella IgM
(Vircell S.L., Spain); SERODIA-MYCO II (Fujirebi Inc., Japan)
for detection of Mycoplasma total antibodies, and microscopic
agglutination test (in-house) for detection of Leptospira total
antibodies. Sarcocystis serology was done at the CDC by an
immunoblot assay using S.neurona merozoite-derived antigens
(personal communication, CDC, Atlanta, USA) in 10 patients.
Magnetic resonance imaging (MRI) of skeletal muscles was
performed in 8 patients who underwent whole-body coronal T2
weighted, T1 weighted and T2 weighted short inversion time
inversion recovery (STIR) scans using the 1.5 T SignaHDx MR
Systems (GE Healthcare, USA).
Muscle biopsies from affected sites in 4 patients with myalgia
and MRI abnormalities were fixed in buffered 10% formalin and
routinely processed. Hematoxylin and eosin stained tissue sections
were examined by light microscopy. Polymerase chain reaction
(PCR) for Sarcocystis spp. was performed on all 4 biopsies (6,7).
Statistical Analysis
Statistical analysis was performed using chi-square testing and
Fisher’s exact test to compare the categorical variables in relation
to patients’ nationality and sex. The Mann-Whitney U-test was
utilized to compare the median duration of symptoms between
nationalities and sexes while Spearman’s rank correlation and
independent samples t-test were used to analyze the relationship
between age and severity of myalgia, and duration of symptoms,
respectively.
IBM SPSS Statistics version 21.0 (Armonk, NY: IBM Corp) was
used for statistical analysis. P values,0.05 were considered
significant.
Ethics Statement
This investigation was undertaken in response to the presenta-
tion of acutely ill patients to our institution with the intent of
determining the infectious agent responsible for the outbreak.
Patients and their guardians were informed throughout their
management that investigations were undertaken to ensure that
critical illness did not develop in any person, to identify the
Author Summary
Sarcocystis species are protozoan organisms that have
been associated with disease in animals but less frequently
so in humans. Following a retreat on Pangkor Island off
Peninsular Malaysia, a number of persons presented to our
hospital with prolonged fever and muscle pain that was
initially difficult to attribute to a known infectious cause.
Investigations, including muscle biopsies and PCR, showed
that this outbreak was most likely due to Sarcocystis
nesbitti infection. The most common clinical features were
fever and myalgia that was relapsing-remitting in more
than half the patients. Some patients had visible swelling
of muscle groups, including of the face, with magnetic
resonance imaging also demonstrating inflammation in
these muscles. Herein, we present the clinical and
investigation findings in 89 symptomatic persons in the
largest reported outbreak of human muscular sarcocysto-
sis to date. Our findings provide insights and suggestions
for the most appropriate forms of investigation, treatment
and possible source of infection.
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causative organism, and, if possible, to determine the mode of
acquisition of infection and henceforth, to prevent further
infection. Ethics or IRB approval was not requested for this
outbreak investigation. All patients who underwent muscle biopsy,
the only invasive test, gave written informed consent. Written
consent was obtained from the patient in Figure 1 for publication
of the photograph.
Results
Clinical Presentation and Features
From 17th to 19th January 2012, a group of 92 college students
and teachers attended a retreat at a hotel located on Pangkor
Island, Malaysia. There were 55 males and 37 females, with a
median age of 35 years (IQR 27 to 44; range, 5 to 64). Seventy-
one were Malaysians and 21 non-Malaysians. A total of 58 cases
were medically assessed at our institute, and 9 were admitted to
hospital.
From a review of available medical records and questionnaire
responses, it was determined that 89 persons demonstrated or
reported features consistent with the case definition. Of these, 53
were male and 36 female with a median age of 34 years (IQR 27
to 43.5). Sixty-nine (77.5%) symptomatic persons were Malaysians
and 20 (22.5%) were non-Malaysians: 9 from China, 3 from
Nepal, 2 each from Korea and Indonesia and 1 person each from
India, Netherlands, Myanmar and Iran, respectively. Malaysians
were older with a median age of 38 years (IQR 27.50 to 45.00)
compared to 29?5 years (IQR 24.25 to 33.75) for non-Malaysians
(p = 0.012).
The onset of symptoms could be accurately ascertained for 82
patients and occurred between day 1 and day 26 post-retreat.
Symptoms began between day 9 and 11 for 58 (70.7%) of these
patients. The most common symptoms and their frequencies are
listed in Table 1. Retreat participants did not report any similar
illness in colleagues or family members who did not attend the
retreat.
Overall, the total duration of symptoms lasted from 3 days to
nearly 4 months with a median duration of 17 days (IQR 7 to 30).
Twenty-seven patients (30.3%) experienced symptoms for 1 month
or longer, myalgia being the most prolonged symptom. There was
no association between age and duration of symptoms, and no
significant difference in median age between the sexes. For non-
Malaysians, the median duration of symptoms was 27.5 days
(IQR, 17.3 to 42.0) which was significantly longer than the 14 days
(IQR, 7.0 to 29.5) experienced by Malaysians (p = 0.001).
In the ‘‘early’’ phase of illness, myalgia was particularly marked
in the neck muscles. Later it was experienced most commonly in
the lower limbs followed by the back and the upper limbs. Among
the 73 persons who graded their myalgia for severity, severe
myalgia was reported by 10 persons (13?7%), moderate myalgia by
27 (37?0%), and mild myalgia by 36 (49.3%). There was no
significant difference in the median age of those with mild or
moderate/severe pain and no significant difference between the
sexes. Sixty-two (89.9%) Malaysians and 19 (95.0%) non-
Malaysians reported myalgia as a symptom but this was not
significantly different. However, 15 out of 18 (83.3%) non-
Malaysians reported myalgia as moderate/severe compared to 22
out of 55 (40.0%) Malaysians (p = 0.002). Thus, non-Malaysians
were more likely than Malaysians to experience moderate/severe
myalgia.
Relapsing fever was reported in 48 of the 84 (57.1%) patients
with fever, and 15 (31?3%) of the relapsing fever cases had 3 or
more cycles of fever. Each symptomatic episode lasted a median of
5 days (IQR, 3 to 7; range, 1 to 21) and each remission 4 days
(IQR 3 to 7; range, 1 to 30). There was no particular pattern
regarding the duration of the first or subsequent cycles. Of the 9
patients admitted to hospital, 8 recorded temperatures greater
than or equal to 39uC.
Between 34 and 38 days post-retreat, 9 patients developed
visible facial muscle swelling with resolution in all patients within 7
days (Figure 1). One of these patients also reported swelling of the
thenar eminence of one hand. Four patients presented with calf
muscle swelling and another patient had isolated swelling of the
interossei muscles of one hand. The higher proportion of non-
Malaysians with muscle swelling (5 cases; 25.0%) compared to
non-Malaysians (9 cases; 13.0%) was not statistically significant.
Cough was reported as non-productive, transient, and seen only
in the first 2 weeks of illness.
Microbiology
Blood cultures from 21 patients were negative for bacteria or
fungal growth. Initial chikungunya IgM serology using immuno-
fluorescent staining (IFAT) was positive in 53% (43/81) of patients.
However, chikungunya IgG serology up to two weeks after onset of
illness confirmed seroconversion in only one patient.
Ten paired patient sera were serologically tested for sarcocys-
tosis including 3 ‘definite sarcocystosis’ cases. There were 3
positive results in both acute and convalescent sera, 2 serocon-
verted positives, 1 equivocal, and 4 cases that were negative for
both acute and convalescent samples. In five patients who had
muscle swelling, 3 had positive results. One of the definite cases of
sarcocystosis had negative serology.
Figure 1. 32 year old student from China with facial swelling
from swollen temporalis and masseter muscles (Case 1,
Table 3).
doi:10.1371/journal.pntd.0002876.g001
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None of the other serology tests for dengue, Legionella,
Mycoplasma or Leptospira were consistent with recent infection.
Blood Test
FBC, LFTs, and CK abnormalities varied according to the
time-point of illness. Those parameters that were most commonly
abnormal ‘early’ or ‘late’ in the course of the infection are shown
in Table 2. Only those symptomatic patients who were reviewed in
the hospital had blood tests performed in the early period.
Magnetic Resonance Imaging
Eight patients who had facial swelling and/or myalgia 4–5
weeks after onset of illness underwent MRI examination. Three
muscle groups, muscles of mastication, calf, and superficial back
muscles demonstrated focal and heterogeneous high signal
intensities on STIR consistent with inflammatory edema and
myositis. Non-affected muscles demonstrated low signals on STIR.
All 8 patients had edema/myositis in the muscles of mastication
(superficial temporalis, deep temporalis and masseter muscles)
(Figure 2). These were bilateral in 5 and unilateral in 3 patients.
Four of these 8 patients had exhibited or reported facial swelling.
Four patients had MRI changes in the back muscles and 2 in the
calf muscles (Figure 3).
Of the patients who underwent MRI, 2 had both eosinophilia
and raised CK, 3 had eosinophilia alone and 3 had only raised
CK.
Muscle Biopsy and Sarcocystis spp. Identification
Four biopsies were taken from the temporalis (1 case), tibialis
posterior (1 case), and gastrocnemius (2 cases) muscles (Table 3). In
3 biopsies (temporalis, tibialis posterior, gastrocnemius), one or
more sarcocysts were detected within muscle fibres by light
microscopy (Figure 4). A whole sarcocyst was also obtained in a
muscle tissue culture preparation from the temporalis muscle. In
all 3 biopsies with sarcocysts, there were no inflammatory cells
immediately surrounding the infected muscle fibre, but mild to
moderate inflammation and focal necrosis was noted in other parts
of the muscle. Inflammatory cells were mixed and eosinophils were
generally not prominent.
We attempted to determine the 18S rDNA sequences from the
sarcocysts and/or muscle tissue of 3 biopsies (temporalis, tibialis
posterior and gastrocnemius muscles) by polymerase chain
reaction (PCR) and direct sequencing [6]. S. nesbitti sequences
(accession numbers HF544323 and 544324) were confirmed in 2
patients (temporalis and gastronemius muscles). The 18S rDNA
gene shared 100% identity with S. nesbitti found in the muscle of
Macaca fascicularis from Yunnan Province, China [9,10,11]. The
presence of S. nesbitti (accession number JX661499.1) was
subsequently confirmed by nested polymerase chain reaction
and sequencing from the gastrocnemius muscle of the fourth
patient (7).
Thus in our series, 4 cases were classified as definite: Three
Malaysians and one non-Malaysian. The clinical features and
laboratory findings of these 4 cases are shown in Table 3.
Treatment
As the etiological agent was not determined until late in the
course of illness, only 3 patients received medical treatment aside
from basic analgesia. Two patients received oral corticosteroids
with 1 patient reporting resolution of symptoms soon after
commencement of treatment but the other did not report any
change.
A third patient received targeted therapy after diagnosis of
biopsy confirmed sarcocystosis 10 weeks into illness. With pre-
Table 1. Frequency of symptoms, duration and site of myalgia reported by patients (n = 89).
Symptom Location/duration of myalgia
Number of patients with symptom/Total number of
patients reporting or affected patients (%)
Fever 84/89 (94.4)
Relapsing fever 48/84 (57.1)
Myalgia Any muscle group 81/89 (91.0)
Lower limbs 57/81 (70.3)
Back 49/81 (60.5)
Upper limbs 46/81 (56.8)
Neck 34/81 (42.0)
Face/jaw 5/81 (6.2)
Duration of myalgia ,1 week 21/81 (25.9)
1 to ,2 weeks 16/81 (19.7)
2 to ,4 weeks 17/81 (21.0)
4 to ,8 weeks 22/81 (27.2)
.8 weeks 5/81 (6.2)
Headache 77/89 (86.5)
Cough 36/89 (40.4)
Joint Pain 35/89 (39.3)
Nausea 25/89 (28.1)
Vomiting 16/89 (18.0)
Diarrhoea 16/89 (18.0)
Rash 4/89 (4.5)
doi:10.1371/journal.pntd.0002876.t001
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existing renal impairment, clindamycin 600 mg qid po and
fansidar (sulfadoxine 500 mg/pyrimethamine 25 mg) 2 tablets/
weekly po were prescribed. After 3 days of treatment, the patient
reported that pain in the proximal arm muscles and thighs had
reduced significantly and proximal arm strength had improved.
There was a decrease in CK from 782 to 653 but this had been
falling prior to institution of medications. Fansidar was taken for 2
weeks with an interrupted course of clindamycin for 6 weeks. At
this point there was no recurrence of myalgia. The patient was
subsequently lost to follow-up.
Exposure Investigation
Water and food contamination were investigated as possible
sources of Sarcocystis infection. The hotel is located adjacent to a
forested area and about 500 m from the beach. The water supply
to the hotel came from two sources: chlorinated (treated) water
from the mainland and untreated ‘‘gravity-feed’’ water piped
down from forested hillsides on the island. Treated water was
meant for drinking and preparing food. Untreated water, intended
for bathing and washing, was apparently filtered and stored in
large outdoor tanks. There was a temporary breakdown in the
treated water supply just prior to the retreat. There were reports of
the water appearing ‘‘cloudy’’ at the beginning of the retreat and it
is possible that untreated water was inadvertently used to prepare
food and drinks during the retreat. All 89 symptomatic persons
who attended the retreat drank water/beverages prepared in the
hotel. As for the 3 persons who did not fall sick, one person drank
only Chinese tea prepared with boiled water, while the other two
reported drinking ‘mostly’ bottled water. All 92 participants ate
meals prepared by the hotel.
Sarcocystis spp.were not detected by PCR in any water samples.
Discussion
This outbreak has previously been described in relation to the
molecular identification of S. nesbitti as a cause of human muscular
sarcocytosis [6,7]. This report adds to the previous work by
providing a comprehensive description of the clinical features of
the illness in a large group of affected persons. The focal point of
exposure allows for the potential incubation period to be estimated
and the temporal changes in both the clinical features and blood
investigation results are clearly demonstrated. The important role
of MRI is also shown with, for the first time, selected images of the
most evident changes. Other aspects of the illness, including
treatment options and a possible modification of illness in
Malaysians, are also discussed. This report incorporates the
clinical, investigative and management aspects of this illness,
adding substantially to the previously reported work.
Our findings strongly suggest that muscular sarcocystosis was
responsible for the outbreak of acute relapsing febrile myositis in
our cohort. Four patients had definite sarcocystosis with sarcocysts
or nucleotide sequences demonstrated in the muscles that were
shown to be involved by MRI. The other 85 patients had probable
Table 2. Peripheral blood parameter results in early and late disease.
Peripheral blood parameter
Time
point
Number of patients with
elevated parameter/number
of patients tested (%)
Median (6109
or IU/L or U/L)
IQR (6109 or
IU/L or U/L)
Number of patients
with both early and
late bloods/changes
with time
Eosinophil count (0.02–0.506109/L) Early 18/57 (31.6) 0.37 0.20–0.54 12/1 elevated early and late, 7
normal early and elevated late, 4
normal early and late
Late 10/15 (66.7) 0.79 0.46–0.99
Lymphocyte count (1.0–3.06109/L) Early 19/59 (32.2) 2.40 1.75–3.39 12/1 elevated early and late, 6
normal early and elevated late, 4
normal early and late, 2 elevated
early and normal late
Late 9/15 (60.0) 3.21 2.30–4.70
Alanine aminotransferase (30–65 IU/L) Early 36/56 (64.3) 86.00 53.00–145.00 25/10 elevated early and late, 1
normal early and elevated late, 4
normal early and late, 10
elevated early and normal late
Late 12/27 (44.4) 63.00 47.00–95.00
Aspartate aminotransferase (15–37 IU/L) Early 39/56 (69.6) 46.00 33.50–62.75 25/12 elevated early and late, 2
normal early and elevated late, 2
normal early and late, 9 elevated
early and normal late
Late 16/27 (59.3) 38.00 29.00–52.00
c-glutamyltransferase (5–55 IU/L) Early 35/56 (62.5) 70.00 39.00–143.25 25/12 elevated early and late, 1
normal early and elevated late, 5
normal early and late, 7 elevated
early and normal late
Late 15/27 (55.6) 61.00 39.00–106.00
Creatine Kinase (26–192 U/L) Early 7/48 (14.6) 95.00 64.5–151.50 7/1 elevated early and late, 5
normal early and elevated late, 1
normal early and late
Late 9/10 (90.0) 921.00 400–1489.00
Early – ,4 weeks after start of retreat. Late – .4 weeks after start of retreat.
doi:10.1371/journal.pntd.0002876.t002
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muscular sarcocystosis as suggested by the clustered time of onset
and recovery from symptoms, overall similarity of symptoms to
definite cases, and absence of similar illnesses among patient
contacts who did not attend the retreat.
Although sarcocysts have previously been noted as incidental
findings in tongue muscles in an autopsy series [5], we believe that
their presence in our cases represents a pathological process.
Sarcocysts have never been detected in more than 1500 limb
muscle biopsies examined at the University of Malaya Medical
Centre (Wong KT, unpublished data), thus finding sarcocysts in
inflamed skeletal muscles from sites other than the tongue is
unlikely to be incidental. In addition, with more than 120
Sarcocystis spp. reported in animals [12] it seems unlikely that 3
cases from our cohort could co-incidentally have the same species
identified by PCR, with 3 cases also demonstrating sarcocysts of
very similar morphology. Although a few previous human studies
have shown that febrile myalgia is associated with biopsy-proven,
muscular sarcocystosis [3,4,13–15], this is the first time that S.
nesbitti has been identified as a cause of symptomatic human
muscular sarcocytosis.
Our results suggest that S. nesbitti has a very high 97% attack
rate. With an identifiable common period of exposure lasting 3
days, the incubation period was determined as most likely to be
between 9 and 13 days, but could be up to 28 days. The most
common symptoms, fever (94%) and myalgia (91%), were non-
specific making initial diagnosis difficult. However, the majority
(57.1%) of cases had relapsing fever. Nine patients exhibited facial
swelling and an additional 4 had MRI changes consistent with
Figure 2. Coronal STIR MRI demonstrating bilateral asymmet-
rical high signal in deep (arrow head) and superficial (arrow)
temporalis muscles (Case 1, Table 3).
doi:10.1371/journal.pntd.0002876.g002
Figure 3. Axial STIR demonstrating heterogenous increased signal right (Rt) tibialis posterior (arrow) compared to non-
oedematous muscles (arrowhead) left (Lt) calf (Case 2, Table 3).
doi:10.1371/journal.pntd.0002876.g003
Figure 4. A single sarcocyst (arrow) within a muscle fibre (Case
4, Table 3). Typically there is mild myositis (w) near the sarcocyst.
Bar = 40 microns. H&E stains,620 objective lens.
doi:10.1371/journal.pntd.0002876.g004
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myositis involving the muscles of mastication. Some of the clinical
features in the present outbreak appear similar to those described
previously. An outbreak involving 6 American military personnel
who were believed to be infected in Malaysia, showed that nearly
half of them had prolonged fever, myositis and raised liver
enzymes [3]. However, there were also reports of bronchospasm,
rashes, lymphadenopathy and marked eosinophilia, features not
found in our patients. One patient had bitemporal muscle
tenderness but facial swelling was not reported. Facial swelling
as a striking clinical manifestation has also been reported more
recently in a Dutch traveler to Tioman Island, Malaysia [15].
Earlier reports of human muscular sarcocystosis often referred
to the disease as an ‘eosinophilic myositis’ [3,14]. However, we
think it important not to exclude this diagnosis on the basis of the
eosinophil count since this could be normal early in disease.
Normal eosinophil counts were also observed in travellers
returning from Tioman Island with possible Sarcocystis-like myositis
[4]. In fact, in our cohort, lymphocytosis appeared to be as
common as eosinophilia throughout the illness.
The apparent clinical differences between our cases and
previous reports could be due to a number of reasons. Firstly, it
is possible that a pathogenic Sarcocystis spp. different from S. nesbitti
was involved as this is the first time species identification has been
successfully performed in human disease. Secondly, the time points
at which patients were reviewed appears to affect results as seen in
the variations in eosinophil counts and serum CK levels within
individual subjects over time. Finally, as the current outbreak
occurred within a single community, it is likely that we may have
included some patients with milder symptoms who would
otherwise not seek medical attention,
Whole body MRI in STIR sequence was helpful to guide the
choice of suitable muscle biopsy sites, resulting in a definitive
diagnosis in all 4 patients biopsied. This is the highest number of
biopsy-proven cases from a single outbreak of symptomatic
sarcocystosis, and MRI had an essential role to play. Despite the
widespread myalgia, the abnormal MRI changes were confined to
3 distinctive groups comprising of the muscles of mastication, the
calves and the back. As discussed, the involvement of the muscles
of mastication represents an interesting disease manifestation. In
contrast to the utility of MRI, serology performed in a limited
number of patients did not appear to be sufficiently sensitive, and
this warrants further investigation before diagnostic use in humans
can be recommended.
Since clinical manifestations and laboratory investigations may
be non-specific, isolated cases of muscular sarcocystosis could be
easily missed, and therefore this condition is also likely to be under
diagnosed. Nonetheless, prolonged relapsing fever and severe
myalgia that lasts several weeks, facial and other muscular
swellings, raised LFT, CK, eosinophilia and lymphocytosis could
suggest the diagnosis. MRI in STIR sequence, by demonstrating
muscles affected by myositis, is a potentially useful tool to guide
muscle biopsy to confirm the diagnosis. It cannot be overempha-
sized that muscle biopsy is most important to confirm the diagnosis
and should be done whenever possible. In fact, the definitive
diagnosis was only made after muscle biopsy. As our study shows,
even in the absence of sarcocysts, the PCR of muscle tissue may be
still be useful for diagnosis if clinical suspicion is high.
Interestingly, our study suggests that the only significant risk
factor for prolonged disease and moderate/severe myalgia is the
patient’s nationality. Non-Malaysians were more likely to suffer
more prolonged disease and to complain of moderate/severe
myalgia than Malaysians. Although perception of severity of pain
may be subjective and possibly influenced by cultural values,
duration of illness is probably less subjective, suggesting that the
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observed statistical significance, at least for duration of illness, may
indeed be true. The histological demonstration of sarcocysts in
21% of Malaysians along with other reports of incidental findings
of sarcocysts in Malaysians suggest that exposure to this organism
may not necessarily result in symptomatic infection [5,16].
However, we speculate that asymptomatic infection could lead
to partial immunity which could help explain the shorter duration
of symptoms and less severe myalgia experienced by Malaysians in
the cohort. It may also explain why all previous reported cases of
symptomatic muscular sarcocystosis from Malaysia involved non-
Malaysians [3,4,13,15].
There are no conclusive recommendations for the treatment of
sarcocystosis [1] although previous reports raise the possibility of
clinical improvement with steroids or albendazole but recovery
was not rapid [3]. In animals, medications including clindamycin,
pyrimethamine and sulphonamides have been suggested as
treatment options [17,18]. There was a previous report of
symptomatic improvement and resolution of blood test abnormal-
ities in human sarcocystosis with the use of co-trimoxazole [14].
We elected to treat one patient with prolonged symptoms, as we
would a case of toxoplasmosis based on the premise that both
organisms are intracellular protozoa. We also elected to utilize
medications that have been effective in animals but co-trimoxazole
was avoided due to renal insufficiency. Hence the patient received
clindamycin and fansidar. It is difficult to attribute the patient’s
subsequent improvement solely to the medications prescribed but
we believe such treatment is worthy of consideration in future
cases.
S. nesbitti was first described in muscle tissues of Macaca mulatta
monkeys by Mandour in 1969 [19]. An ultrastructural study of
human muscular sarcocystosis in Malaysia has previously shown a
similarity to sarcocysts found in Macaca fascicularis (Malaysian long
tailed macaque) [20]. Phylogenetic analysis suggests that snakes
could be a definitive host [10,19]. More recently, S. nesbitti
sequences have been detected in the feces of snakes from disparate
parts of Malaysia, confirming that snakes may be the definite hosts
[7,11]. As such, S. nesbitti is likely to be endemic in the country. We
have no evidence for any recent change in ecology of snakes or
human/snake interaction to account for the recent cases although
further investigations are needed. Reports of 100 foreign persons
with an acute muscular Sarcocystis-like illness after returning from
Tioman Island, Malaysia, between 2011 and 2012 [4] could either
suggest a reemerging infection or an increasing recognition of an
endemic disease. It is possible that S. nesbitti could cause a clinically
more apparent disease compared to other Sarcocystis spp. that could
potentially cause human sarcocystosis. Moreover, it is not known if
the severity of clinical disease is dependent on the dose of
sporocysts consumed or if a low dose results in largely
asymptomatic infection.
Infection in this outbreak is likely due to consumption of water
contaminated by snake feces. Almost all the water supply in
Malaysia are sourced from streams or rivers, so contamination by
snake or other reptile feces may be common. We believe that
drinking gravity-feed water contaminated by snake feces or
ingestion of uncooked food washed therein, is most likely to be
responsible for this outbreak. Water treatment by chlorination
may not be able to kill sporocysts [21], thus contaminated piped
water from the mainland could still be responsible, albeit less likely
as the contaminants are likely to be diluted by a significantly larger
water supply. Unsafe water supply, especially in the islands and
other remote places, poses potentially serious public health risks
that will require urgent investigation and intervention. Travellers
should be advised to only drink boiled or bottled water and to
avoid uncooked food [21]. There should also be heightened
awareness for this infection in patients who have recently lived in
or travelled to Southeast Asia.
There were some limitations to our study. Firstly, since it was
commenced as an outbreak investigation and the diagnosis was not
known until well into the course of the illness, investigations and
their timing could not be more uniformly undertaken for all the
patients. Secondly, in determining the severity of myalgia the
adopted definitions may not be mutually exclusive, and other
factors, including cultural, may also have influenced the percep-
tion of pain. Finally, due to ethical and other considerations, it was
neither possible nor appropriate to perform further muscle
biopsies.
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